Why govt's plan to cap prices of more drugs may have a silver lining for investors

Premium
Credit: Thinkstock

Indian pharmaceuticals companies, which are striving hard to maintain its growth and facing greater regulatory pressure in their......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.